Ahmedabad: Following allegations of medical negligence, the Ahmedabad Municipal Corporation (AMC) has ordered an inquiry after a woman died during treatment at SVP Hospital on Wednesday. The incident gained widespread…
Generic versions of Novo Nordiskās Wegovy and Ozempic medications could be mass produced for about $3 per person a month, according to a new analysis.
New Delhi: The Supreme Court has dismissed a criminal appeal filed by SBS Biotech and its officials, upholding the Himachal Pradesh High Court's decision refusing to quash prosecution proceedings initiated…
Gandhinagar: In a move aimed at improving access to medicines through public healthcare facilities, the Gujarat government has expanded its Essential Drug List (EDL) for the year 2025-6. The updated…
Hyderabad: Granules India Limited has announced that its US packaging facility operated by Granules Consumer Health LLC has received an Establishment Inspection Report (EIR) with No Action Indicated (NAI) status…
New Delhi: The domestic pharma industry is staring at a loss ranging between Rs 2,500 crore and Rs 5,000 crore due to the various supply and freight movement disruptions owing…
USA: Dupilumab significantly reduced itch and hive severity in patients with chronic spontaneous urticaria (CSU) who remained symptomatic despite antihistamine therapy, findings from the phase 3 LIBERTY-CSU CUPID trials published…
Bengaluru: The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making āit the ā third ā drug cleared under the agency's new…
Extremely preterm birth (EPB), defined as delivery before 28 weeks of gestation, poses significant challenges in maternalāfetal medicine, affecting approximately 2ā5 per 1,000 pregnancies. This condition is associated with severe…
USA: A phase 2a pilot trial evaluating dual costimulatory blockade with dazodalibep plus belatacept suggests this approach may improve immunosuppression adherence and offer a non-calcineurin alternative for kidney transplant recipients.…